Daniel Loeb

Daniel Loeb

Last Update: 04-13-2016

Number of Stocks: 27
Number of New Stocks: 3

Total Value: $9,854 Mil
Q/Q Turnover: 10%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Daniel Loeb Watch

  • Analyzing Daniel Loeb's Top Buys: Masco Corporation

    Daniel Loeb (Trades, Portfolio) is well known activist investor. He founded Third Point LLC in 1995 and leads the firm’s research activities, portfolio, and risk management. Third Point’s total assets are more than $2.2 billion, and Loeb’s personal net worth is $2.3 billion.


    Last quarter, Loeb bought 1.9 mn shares of Masco Corporation (NYSE:MAS). As of December 31, 2014, he was holding 10 mn shares of the company. The following chart shows Dan Loeb's holding history in the company.

      


  • Daniel Loeb's Comments on Fanuc

    During the fourth quarter we invested in Fanuc ( FANUY), the leading factory automation and robotics company in the world with a market capitalization of $33 billion and an enterprise value of $25 billion. Based in Japan and spun out of Fujitsu in the 1970’s, Fanuc is a unique company with a long history of being the best and fastest to market in everything it does. Its visionary founder describes the Company’s mission as “walking the narrow path,” which refers to its relentless focus on producing only a limited number of products that are technically superior with the lowest possible cost structure. This targeted innovation combined with a strong emphasis on reliability and service has made virtually all of Fanuc’s products blockbusters. While serving completely different, cyclical markets, Fanuc reminds us of Apple in its product approach.


    In its core Factory Automation division, Fanuc has capitalized on structural growth in automation by creating a huge moat in Computerized Numerical Control (“CNC”) systems and servo motors. It has become the global standard for machine tool control software and motors with a worldwide market share of 60%. The Company has built a global service/aftermarket support organization that is unrivaled by competitors in a business where switching costs are high. The division’s revenue correlates closely to Japanese machine tool orders, which are on the rise for multiple reasons including strong demand from the US and a depreciating yen. Additionally, Chinese factory automation is a substantial growth opportunity as rising wages, low productivity, and quality issues force companies in the region to automate. To get a sense of the opportunity: China’s CNC penetration rate of 30% today equals Japan’s levels 40 years ago. Fanuc is expanding CNC capacity by 40% in the next twelve months to meet these higher demand levels. Fanuc’s Robots division has achieved a cumulative sales growth of 60% in the past two years, capitalizing on a robust opportunity set across all major economies. In China, automotive industry robot density is still at less than 15% of the levels seen in Japan, while general industry robot density is at less than 5% of Japan’s. In Japan, capital equipment replacement demand, some re-shoring of manufacturing and labor shortages are creating multiple drivers for robot demand. The resurgence in US manufacturing is also providing strong demand, as automotive and general industry customers are increasing orders for lifting, picking, welding, painting, and dispensing robots. Virtually every large manufacturing footprint expansion in North America – from Airbus to Ford to Tesla – is taking place with Fanuc’s robots. Fanuc’s internal development of low cost full artificial vision systems and collaborative robots makes it best positioned to drive adoption in industries that have traditionally been unable to automate. We think that these innovations will double the size of the Robots division in only a few years.

      


  • Investors Should Bet on this New York City-Based Insurer

    In this article, let's take a look at American International Group, Inc. (NYSE:AIG), a $75.29 billion market cap company that is a leading international insurance organization, which was rescued by various government entities in the financial crisis of 2008.


    Reverting 2008 crisis

      


  • Analyzing Daniel Loeb's Top Picks: eBay Inc (EBAY)

    Daniel Loeb (Trades, Portfolio) founded Third Point LLC in 1995 and leads the firm’s research activities, portfolio, and risk management. He is well known for his public letters in which he criticizes company CEOs or other investment managers. Third Point’s total assets are more than $2.2 billion, and Loeb’s personal net worth is $2.3 billion. Loeb and Third Point focus on activist investing, and follows an event-driven, value-oriented investment style. Loeb identifies situations in which a catalyst will unlock value. Last quarter Daniel Loeb (Trades, Portfolio) increased his holdings in eBay (NASDAQ:EBAY) by 122%. He currently holds 10 mn shares of the company. Here's a look at the company in detail.


    Company overview

      


  • Paul Tudor Jones Is Betting on the SPY, Should You?

    Over the past days hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings by filed institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission (SEC).


    Hedge funds bought more than 15 million shares of the SPDR S&P 500 ETF Trust (SPY) worth $3.4 billion last quarter, according to data from 13-F filings compiled by Bloomberg. This ETF was the third-biggest aggregate increase in position by market value.

      


  • Why Hedge Fund Titans Like Delta Airlines (DAL)

    With crude prices declining, many investors are getting interested in airline stocks. Delta Airlines (NYSE:DAL), in particular, has seen many big name investors like Daniel Loeb (Trades, Portfolio), Julian Robertson (Trades, Portfolio), John Griffin (Trades, Portfolio), Mario Gabelli (Trades, Portfolio), Ken Heebner (Trades, Portfolio) and Whitney Tilson (Trades, Portfolio), buying its shares last quarter. The company's stock price has gained ~300% since the beginning of 2013, but its relative valuation is still one of the lowest among all S&P Industrial companies (see graph below).


    Delta's Relative Valuation versus S&P industrials

      


  • Daniel Loeb's Top 5 New Stock Buys of the Fourth Quarter

    Daniel Loeb (Trades, Portfolio), the CEO of hedge fund known for its periodic activist ventures Third Point, had significant portfolio turnover of 40% in the fourth quarter, with 12 new stocks added.


    In his fourth quarter shareholder letter, Loeb discussed his investing point of view for the current environment:

      


  • Daniel Loeb Comments on Fanuc Corp

    Equity Position: FANUC (TSE:6954, FANUY, FANUF)


    During the fourth quarter we invested in Fanuc (the “Company”), the leading factory automation and robotics company in the world with a market capitalization of $33 billion and an enterprise value of $25 billion. Based in Japan and spun out of Fujitsu in the 1970’s, Fanuc is a unique company with a long history of being the best and fastest to market in everything it does. Its visionary founder describes the Company’s mission as “walking the narrow path,” which refers to its relentless focus on producing only a limited number of products that are technically superior with the lowest possible cost structure. This targeted innovation combined with a strong emphasis on reliability and service has made virtually all of Fanuc’s products blockbusters. While serving completely different, cyclical markets, Fanuc reminds us of Apple in its product approach.

      


  • Daniel Loeb Comments on Amgen Inc

    Equity Position: Amgen (AMGN)


    Our biggest winner in 2014 was our equity position in the biotechnology company Amgen. In our last letter and at the Robin Hood Investment Conference, we highlighted Amgen as a hidden value situation where investor skepticism in three areas – R&D productivity, operating efficiency, and capital allocation – had obscured the company’s fundamental value.

      


  • Daniel Loeb’s Third Point Q4 2014 Investor Letter

    Review and Outlook


    Since the financial crisis, managing volatility and risk has proven to be almost as important as good stock-picking in generating investment returns. Last year emphasized this lesson, as investors struggled to cope with five drawdowns of greater than 3.9% in the SPX followed by swift rebounds within weeks. Third Point’s mediocre 2014 results, +5.7% in Offshore and +6.8% in Ultra, were due to a combination of poor trading during market volatility and bad judgment in exiting positions for reasons ranging from “overstaying our welcome” to impatience seeing our thesis through in choppy markets. Fortunately, there were bright spots in structured finance and enough winners in equity and government credit to help us eke out a mid-single digit return for our investors.

      


  • Why Soros, Burbank and Cohen Bought this Fairly Valued Stock

    In this article, let's take a look at Anheuser-Busch InBev SA/NV(NYSE:BUD), a $184.78 billion market cap company that is a brewing company and manages a portfolio of over 200 brands of beer.


    Good dividend yield

      


  • Different Hedge Fund Managers Bought and Added Molson Coors Brewing

    In this article, let's take a look at Molson Coors Brewing Company (NYSE:TAP), a $14.01 billion market cap company, which is the fifth largest brewer in the world, was formed in early 2005 via the combination of Adolph Coors Co. and Molson, Inc.


    Light Beer

      


  • The Broken-Leg Problem: Q&A with Abnormal Returns’ Tadas Viskanta about Deep Value

    Earlier this week I did a Q&A withAbnormal Returns’ Tadas Viskanta about Deep Value. Tadas sees more finance and investing content than anyone else, so it’s always interesting to see what he takes away from a topic:


      


  • Daniel Loeb Comments on Sony Corp

    In May of 2013, Third Point announced a significant stake in Sony (SNE) and suggested to the company’s CEO, Kazuo Hirai, that he should seriously consider spinning out 15‐20% of the company’s undervalued, American-based Entertainment business. At the time, we explained that partially listing the Entertainment segment would have three positive effects: 1) highlighting its profitability; 2) increasing investor transparency, thereby allowing the market to properly benchmark the company against its global media peers; and 3) incentivizing Entertainment’s management to run the company more efficiently by engaging in cost cutting and laying out clear earnings targets.


    While, regrettably, the Company rejected our partial spin-out suggestion, they made some changes that were consistent with our goals. In the Entertainment business in particular, Sony has cut costs, improved its dialogue with investors, and undertaken key management changes. In Electronics, Mr. Hirai’s team deserves credit for transitioning away from personal computers this year and improving television profitability in 2015. They have also improved investor transparency. Still, they have a long way to go and we continue to believe that more urgency will be necessary to definitively turn around the company’s fortunes.

      


  • Daniel Loeb Comments on Alibaba Group Holding Ltd

    In our Quarterly Letter two and a half years ago, we argued “the Case for Alibaba.” At the time, Alibaba (BABA) held a leading market position that it was just beginning to monetize (the company had less than $75 million in LTM earnings). Today, the Company has continued its exponential growth, demonstrated significant margin leverage, and is expected to earn over $5 billion this fiscal year. Our enthusiasm for the Alibaba story has underpinned multiple investments at Third Point and now that the company is public, we have established a significant direct investment in Alibaba shares.


    Third Point has met with management several times and is confident that Alibaba can generate long‐term value in its core markets and compete in new ones, making it a compelling potential multi‐year investment. The company has a substantial network effect that creates several large moats around its business, generating significant free cash flow for re‐investment and expansion as well as an unrivaled amount of data on Chinese consumers. We see continued end market growth in Chinese consumer spending and e‐ commerce (as well as global e‐commerce) and continue to believe that Alibaba has considerable additional monetization potential.

      


  • Daniel Loeb Comments on eBay

    We established a significant position in eBay (EBAY) during the Third Quarter. While eBay’s challenges were well‐mapped – including multiple years of minimal value growth, a weak execution track record, and high employee turnover – we sensed it had arrived at a critical inflection point and gained new focus. A meeting with CEO John Donahoe this summer left us impressed by his process‐driven approach to optimizing the business.


    We were pleased when Mr. Donahoe announced in September that eBay would split into two by spinning off its PayPal unit. Our work on Alibaba (BABA) since 2011 had persuaded us of the power of the marketplace model in e‐commerce and our work on AliPay convinced us that PayPal was an incredibly well‐positioned global brand with the potential to become a leading player in mobile payments. Following the spinoff, eBay/PayPal will offer two appealing growth, relative value, and capital return profiles for investors.

      


  • Daniel Loeb Comments on Amgen Inc

    Since its founding in 1980, Amgen (AMGN) (“the company”) has been a pioneer in the biotechnology industry, successfully discovering, developing, and marketing therapeutic agents that have meaningfully impacted human health. From 1989 to 2002, Amgen grew five revolutionary biologic drugs into billion dollar blockbuster products in oncology, nephrology, and inflammation. Today, Amgen is a $105 billion market cap company with annual revenues of nearly $20 billion and annual net income e of over $5billion.


    Considering this track record, Amgen’s long‐term underperformance relative to its biotech peers is surprising. The company has a compelling mix of long‐duration, high‐margin mature products like Neulasta and Enbrel, and a number of exciting high growth assets, including recently launched blockbusters like Prolia and Xgeva along with innovative late-stage pipeline assets like evolocumab. Yet, using nearly any valuation metric, the Company trades at a substantial discount to peers. Amgen even trades at a discount to the US pharmaceutical sector, despite superior revenue and earnings growth rates. Amgen’s current discount to fair valuation – and the lack of structural hurdles to closing this gap – make it an attractive investment opportunity. Third Point is now one of the company’s largest shareholders.

      


  • Third Point Q3 2014 Investor Letter

    This is the excerpt from the shareholder letter of Third Point Capital.


    Going forward, we expect that the US will remain the best place to invest, credit opportunities will stay slim, and large cap opportunities with a constructivist angle will become more promising. Although consensus has shifted to lower growth, slower inflation, modest rates, and continued monetary expansion, we think the markets will resume an overall upward trajectory in the US through year‐end.

      


  • Invest In These Hedge Funds At A Discount

    As of the close on 10/13/2014, Greenlight Reinsurance (GLRE), Third Point Reinsurance (TPRE), and Pershing Square Holdings (AEX:PSH) were selling at discounted prices compared to their book values. These three companies are led by 3 of the top investing gurus we follow, David Einhorn, Daniel Loeb, and Bill Ackman.


    Einhorn and Loeb are following the Warren Buffett model of using the float from an insurance company to essentially make investments on what is similar to an investment free loan. When insurance premiums are collected, the capital has to stay with the company in order to pay out the claims. The premiums collected, but not paid out yet, are referred to as float. As long as the underwriting business is profitable, the float mimics an interest free loan. A common metric used is the combined ratio. A ratio of 100 is break-even, and the lower the number, the more profitable the business. The underwriting profit is simply measured as premiums received minus expenses. In some years, claims might be higher due to certain events, so enough liquidity must be retained to pay them out. Most insurance companies invest the float in fixed income to generate extra cash flow and increase profits. The float from Greenlight Re and Third Point Re is managed by the hedge funds Greenlight Capital and Third Point. Einhorn is the manager of Greenlight Capital and Loeb is the manager of Third Point.

      


  • Caxton Associates Bought this Stock

    In this article, let´s consider Anheuser-Busch InBev SA/NV (NYSE:BUD), a $180.02 billion market cap. which has a trailing P/E ratio that indicates that the stock is relatively undervalued (PE 21.9x vs Industry Median 24.8x).


    So in this article, let's take a look at a model which is applicable to stable, mature, dividend-paying firms and try to find the intrinsic value of the stock. Although the model has a number of characteristics that make it useful and appropriate for many applications, it is by no means the be-all and end-all for valuation. The purpose is to force investors to evaluate different assumptions about growth and future prospects.

      


  • Dow Chemical´s Promising Future

    In this article, let's take a look at The Dow Chemical Company (NYSE:DOW), a $65.41 billion market cap company, which is the largest U.S. chemical company and provides chemical, plastic andagricultural products as well as services.


    Portfolio Mix

      


  • Daniel Loeb's New Stocks

    Dan Loeb is CEO of Third Point LLC, founded in 1995, where he oversees all investment activity. Third Point describes its underlying strategy as “event-driven, value-oriented,” and says it “seeks to identify situations where we anticipate a catalyst will unlock value,” on its website.

      


  • Top Hedge Fund Managers Are Buying Ally Financial

    Now that the investment management firms have filed their Form 13Fs with the SEC, we can gain better insight into which securities the investing gurus are buying and selling. The S&P 500 Grid at GuruFocus can be used to find the top buys, sells and net buys based on a number of different categories.


    Using the grid, I found that many of the investing gurus have been initiating positions in Ally Financial (ALLY). There were 10 buyers of the stock in the second quarter and none of the gurus we follow have sold any shares. The buyers include hedge funds titans such as George Soros (Trades, Portfolio), Daniel Loeb (Trades, Portfolio), John Paulson (Trades, Portfolio), Howard Marks (Trades, Portfolio), and Jeremy Grantham (Trades, Portfolio). There is no other stock that has had as many buyers without at least one other manager selling. Daniel Loeb (Trades, Portfolio) of Third Point LLC has the largest position of 45.595 million shares, representing 9.45 percent of the shares outstanding and 13.4 percent of his portfolio. He actually obtained his position in private transactions prior to the IPO that occurred on April 10 of this year.

      


  • Which Is The Better Buy?: Einhorn's Greenlight Re or Loeb's Third Point Re

    Within the past week both Greenlight Re (GLRE) and Third Point Re (TPRE) released their second quarter earnings for 2014. The reinsurance companies both have investing gurus we follow running the investment portfolios. David Einhorn handles the portfolio for Greenlight Re, and Daniel Loeb is in charge of Third Point Re’s portfolio. Einhorn and Loeb started their long/short hedge funds in the mid-1990s and have had annual gains of about 20 percent each since inception.


    The two reinsurance companies are ways to gain access to the hedge funds while potentially receiving even higher returns if the insurance underwriting businesses are profitable. The metric that insurance companies use to measure underwriting profits is the combined ratio. A combined ratio of 100 indicates break even and the lower the number, the more profitable the underwriting business is. Greenlight Re and Thirdpoint Re are both relatively new companies, and it takes time to establish the insurance business so it can provide consistent underwriting profits. Greenlight Re has already reached the point of consistent profits, but Third Point Re is still developing its business and is not yet there.

      


  • Global Market Valuations And Expected Returns - August 6, 2014

    In January 2014, the U.S. stock market benchmark S&P 500 lost 3.36% after the excellent 2013. The enthusiasm went back as the market gained 4.31% over February. In March, it went up only 0.69%. In April, it was about even for the whole month. In May, the market gained 2.10% and in June, the market benchmark S&P 500 went up 1.91%. However, in July, the market went down by 1.51%.


    What is the situation in the other parts of the world? In July, the key indexes in Europe had negative return figures. Germany’s DAX index declined 4.33%. France’s CAC-40 index lost 4.00%. The FTSE 100 index moderately went down by 0.20%. Stock markets performances in Asia were very strong. Japan’s NIKKEI 225 gained 3.03%. Hong Kong’s Hang Seng Index surged 6.75% and China’s SSE Composite index surged 7.48%.

      


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)